Asia-Pacific PCR Multiplex Assays Market – Industry Trends & Forecast to 2026
Short Description
By Products & Services (Reagents & Consumables, Instruments & Accessories, Software and Services), Applications (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Country (China, Japan, India, Australia, Singapore, Indonesia, Thailand, South Korea, Malaysia, Philippines and Rest of Asia-Pacific)
Market Definition:
The multiplex assays can be applied for detection of pathogens and causing agents of infectious diseases such as viruses, bacteria and parasites. With the wide application of the PCR multiplex assays in drug discovery, bio marker discovery, clinical research and diagnostic of infectious diseases and genetic disorders in research and development laboratories, leading the manufacturers to advances the multiplex assays by overcoming the challenges of the optimization of PCR multiplexes. The PCR multiplex can be distinguished in single template PCR reaction and multiple template PCR reaction.
The automated PCR system is designed with the advanced technology which can detect multiple targets in single test. Quanterix (U.S.) offers Quanterix SR-Plex benchtop instrument which is designed with automated HD-1 Analyzer which helps in the detection of measurement of biomarkers with extraordinary sensitivity. The instrument utilizes single molecule measurements to evaluate previously undetectable proteins and reduces sample volume.
The simultaneously amplification of the multiple sequences in a single reaction is a cost effective, adequate, rapid and accurate procedure of clinical research laboratories. For the multiplex reaction with PCR primer, is required for successful reaction of multiplex. The PCR multiplex assays are designed for high throughput SNP genotyping, pathogen identification, mutation analysis, gene deletion analysis, linkage analysis, template quantitation, RNA detection and other forensic studies.
Market Segmentation:
Asia-Pacific PCR multiplex assays market is segmented into three notable segments which are products & services, application and end user.
• On the basis of products & services, the market is segmented into reagents & consumables, instruments & accessories and software and services.
• On the basis of application, the market is segmented into research & development and clinical diagnostics.
• On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others.
Market Players
The key market players are listed below
• Thermo Fisher Scientific Inc.
• Luminex Corporation
• BD
• QIAGEN
• Agilent Technologies Inc.
• Meso Scale Diagnostics, LLC
• Randox Laboratories Ltd.
• Bio-Techne, Seegene Inc.
• Olink
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Abcam Plc
• Quanterix
• Sysmex Corporation
• Siemens
• F. Hoffmann-La Roche Ltd
• Hologic Inc.
• Diasorin
• Abbott
• Quest Diagnostics Incorporated
• PerkinElmer Inc.
• Eurofins Scientific
• Agena Bioscience, Inc.
The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook